Medicare drug bill could lend boost to ADAPs.
Although it's still a long way from becoming a reality, a Medicare prescription drug bill could be one solution to funding problems experienced by AIDS Drugs Assistance Programs (ADAPs), whose client lists are growing faster than their funding. While Medicaid expansions through waiver programs would also be useful, those types of efforts require committed state governments and completion of a lengthy bureaucratic process. And as the recent National ADAP Monitoring Project Report notes, federal-level initiatives to allow states to expand Medicaid coverage to low-income, non-disabled people living with HIV have not succeeded.
D000368:Aged; D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D004608:Eligibility Determination; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D008484:Medicaid; D006278:Medicare / Q000331:legislation & jurisprudence*; D014481:United States
D019380:Anti-HIV Agents